bluebird bio Inc (BLUE) Stock: Do Analysts Think You Should Buy?

Monday, March 20, 2023 03:44 PM | InvestorsObserver Analysts

Mentioned in this article

Analysts who follow bluebird bio Inc (BLUE) on average expect it to increase 61.93% over the next twelve months. Those same analysts give the stock an average rating of Hold. That average rating earns the stock an Analyst Ranking of 6, which means it ranks higher than 6 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating BLUE a Hold today. Find out what this means to you and get the rest of the rankings on BLUE!
See Full BLUE Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With bluebird bio Inc Stock Today?

bluebird bio Inc (BLUE) stock is lower by -1.87% while the S&P 500 has gained 0.84% as of 3:31 PM on Monday, Mar 20. BLUE has fallen -$0.09 from the previous closing price of $4.54 on volume of 2,416,422 shares. Over the past year the S&P 500 has fallen -11.47% while BLUE has fallen -7.28%. BLUE lost -$6.96 per share the over the last 12 months. Click Here to get the full Stock Report for bluebird bio Inc stock.

Share this article:

Related Articles